Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zoetis, Merck Animal Health and Biogénesis Bagó have all won Animal Pharm Awards in 2018 – adding to their accolades from previous years.
Italian companion animal health company Candioli aims to grow the European horizons of its latest acquisition.
Animal Pharm is teaming up with Kisaco Research to host a webinar dedicated to investment in the animal health industry.
US financial services firm Canaccord Genuity believes Heska is an ideal acquisition target for animal health companies.
Grey Wolf Animal Health has purchased fellow Canadian company Veterinary Healthcare Solutions (VHS).
Neogen has acquired the assets of the Delta Genomics Centre – a animal genomics laboratory in Edmonton, Canada
In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.
US animal health firm Vets Plus has purchased fellow Wisconsin-based company Merrick's – a manufacturer of boluses, tablets, powders and electrolytes for the livestock sector.
MSD Animal Health's has purchased Zhejiang ZhengliAntoo Biotech – a privately owned veterinary vaccine specialist based in China – for an undisclosed fee.
The new standalone public entity that will be formed by the spin-off of Henry Schein Animal Health and its merger with Vets First Choice will be called Covetrus.
UK-based Hallmarq Veterinary Imaging has executed a management buyout, which was supported by mid-market private equity firm August Equity.
UK firm Dechra Pharmaceuticals has completed its acquisition of Laboratorios Vencofarma do Brasil (Venco) for R$185 million ($49.7 million).
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.